(1S,4aR,6R,6aR,9S,11aS,11bR,12R)-1,6,12-trihydroxy-4,4,11b-trimethyl-8-methylenedodecahydro-6a,9-methanocyclohepta[a]naphthalen-7(1H)-one

Catalog No. :
ACVXJS343
CAS No. :
39388-57-3
Molecular Formula :
C20H30O4
Molecular Weight :
334.46

IUPAC Name:(1S,4aR,6R,6aR,9S,11aS,11bR,12R)-1,6,12-trihydroxy-4,4,11b-trimethyl-8-methylenedodecahydro-6a,9-methanocyclohepta[a]naphthalen-7(1H)-one

(1S,4aR,6R,6aR,9S,11aS,11bR,12R)-1,6,12-trihydroxy-4,4,11b-trimethyl-8-methylenedodecahydro-6a,9-methanocyclohepta[a]naphthalen-7(1H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1S,4aR,6R,6aR,9S,11aS,11bR,12R)-1,6,12-trihydroxy-4,4,11b-trimethyl-8-methylenedodecahydro-6a,9-methanocyclohepta[a]naphthalen-7(1H)-one
IUPAC Name(1S,4aR,6R,6aR,9S,11aS,11bR,12R)-1,6,12-trihydroxy-4,4,11b-trimethyl-8-methylenedodecahydro-6a,9-methanocyclohepta[a]naphthalen-7(1H)-one
MDL No.MFCD17214882
Molecular FormulaC20H30O4
Molecular Weight334.46
SMILESC=C1C(=O)[C@@]23[C@H](O)C[C@@H]4C(C)(C)CC[C@H](O)[C@@]4(C)[C@@H]2CC[C@@H]1[C@H]3O
InChI KeyVSDVMWBRICFVRW-BIGDWJEQSA-N
SynonymKamebanin;Kaur-16-en-15-one,1,7,14-trihydroxy-, (1a,7a,14R)-;Kaur-16-en-15-one, 1,7,14-trihydroxy-, (1α,7α,14R)-;(1R,4R,9R,10R)-2,8,16-Trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecan-15-one
CAS No.39388-57-3

Synthetic Route by SureRoute

1. ACVXJS343 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVXJS343 route product structure diagram
    ACVXJS34339388-57-3
Inquiry

2. ACVXJS343 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVXJS343 route product structure diagram
    ACVXJS34339388-57-3
Inquiry

Comments (0)